Mobile navigation menu modal
Learn more about what our experts think about topical subjects.
In an era where digital transformation is accelerating at an unprecedented pace, businesses must evolve to remain...
Suzie Flowers, Principal Medical Writer at ApotheCom, explores the key differences between RNA and gene therapies and why clear terminology is crucial
Congresses are an excellent way to engage with oncologists, HCPs, and other key stakeholders.
Inizio Medical today proudly launches a new campaign that calls on the MedComms industry to do more to promote greater diversity in the sector.
Download Inizio Medical's 2024 Annual Meeting of ISMPP
In part one of our roundtable discussions, Inizio experts predicted the 2024 trends in the medical affairs market and discussed the challenges...
In part one of this roundtable discussion, Inizio experts predict the 2024 trends in the medical affairs market and discuss the challenges and...
When bringing cell and gene therapies (CGTs) to market, developers must successfully navigate various obstacles, including the technical aspects of...
Rare diseases impact millions globally. Advancements in diagnosis, patient-centered care, and digital health are transforming treatment.
Overcoming US and EU launch challenges for biotech products requires early commercial insights, strategic planning, and expert partnerships.
Emerging biotechs often face unique challenges compared to larger, more traditional pharmaceutical companies.
